Mitomycin C (Teva) Inj 5 mg and 20 mg vial: Hospital supply issue

Supply issue Hospital only Active

There are supply issues affecting Teva mitomycin C 20 mg vial (pharmacode: 2601761) and the Accord brand of mitomycin C 5 mg vial (pharmacode 2137844),

On this page

31 October 2024 Update

Resupply of Mitomycin C inj 20 mg vials (Pharmacode 2601761) has been delayed. We are working with the supplier to understand when it will be resupplied. The Omegapharma alternative remains available.

Mitomycin C inj 5 mg vial

Affected product

PCT only- Specialist

  • Presentation: Inj 5 mg vial
  • Brand: Teva
  • Pharmacode: 2137844
  • Subsidy: $641.70
  • Measure / Qty: per 1

This presentation is listed 'any brand' in the HML.

Alternatives listed 

Like the Accord product, these brands are not Medsafe approved and need to be prescribed and dispensed in line with section 29 of the Medicines Act.

  • Brand: Mitomycin Sagent
  • Pharmacode: 2686937
  • Pack size: 1
  • Subsidy: $526.00
  • Available to order through Link
  • Brand: Mitomycin Fresenius Kabi
  • Pharmacode: 2677016
  • Pack size: 1
  • Subsidy: $577.50
  • Available to order through CDC

Mitomycin C inj 20 mg vial

Affected product

PCT only- Specialist

  • Presentation: Inj 20 mg vial
  • Brand: Teva
  • Pharmacode: 2601761
  • Subsidy: $1250.00
  • Measure / Qty: per 1

Alternative listed 

Teva has sourced a supply of Omegapharma mitomycin C, which will be supplied under Section 29 until the Teva brand is back in stock. Teva has supplied the Omegapharma brand before, but registration has now lapsed.

This stock will have Australian packaging.

  • Presentation: Inj 20 mg vial
  • Brand: Omegapharm
  • Unapproved medicine supplied under Section 29.
  • Pharmacode: 2580160 
  • Subsidy: $1250.00
  • Measure / Qty: per 1

Information about Omegapharm mitomycin C on the Australian Medicinewise website(external link)

Expected resupply

We are working with Teva (the supplier) to understand when the Teva brand mitomycin C (inj 20 mg vial) will be resupplied. 

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.

Sign up to our email list for regular emails about supply issues and more(external link)